4.5 Review

Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan

期刊

EUROPEAN NEUROPSYCHOPHARMACOLOGY
卷 28, 期 10, 页码 1059-1088

出版社

ELSEVIER
DOI: 10.1016/j.euroneuro.2018.08.001

关键词

Developmental trajectory; Treatment; Comorbidity; Cognitive impairment; Genetics; Adult-onset ADHD

资金

  1. European Community [602805, 603016, 278948, 602450, 643051, 667302]
  2. Netherlands Organization for Scientific Research (NWO)
  3. Vici Innovation Program [016-130-669]
  4. BMBF (BipoLife)
  5. DFG [CRC 1193]
  6. Hungarian Brain Research Program [NAP-B KTIA_NAP_13-2014-0011]
  7. 1 + 3 PhD studentship - MRC Social, Genetic AMP
  8. Developmental Psychiatry Centre, King's College London [G9817803]
  9. Spanish Ministerio de Economia y Competitividad [SAF2015-68341-R]
  10. AGAUR, Generalitat de Catalunya [2014SGR932]
  11. Instituto de Salud Carlos III [PI12/01139, PI15/01789]
  12. Agencia de Gestiod'Ajuts Universitaris i de Recerca-AGAUR
  13. Generalitat de Catalunya [2014SGR1357, 2014SGR0932]
  14. Departament de Salut
  15. Generalitat de Catalunya, Spain
  16. Instituto de Salud Carlos III, Ministerio de Economia, Industria y Competitividad, Spain [CP09/00119, CPII15/00023, PI14/01700, PI17/00289]
  17. NARSAD Young Investigator Grant from the Brain AMP
  18. Behavior Research Foundation
  19. MRC [G9817803] Funding Source: UKRI

向作者/读者索取更多资源

Attention-deficit/ hyperactivity disorder (ADHD) is highly heritable and the most common neurodevelopmental disorder in childhood. In recent decades, it has been appreciated that in a substantial number of cases the disorder does not remit in puberty, but persists into adulthood. Both in childhood and adulthood, ADHD is characterised by substantial comorbidity including substance use, depression, anxiety, and accidents. However, course and symptoms of the disorder and the comorbidities may fluctuate and change over time, and even age of onset in childhood has recently been questioned. Available evidence to date is poor and largely inconsistent with regard to the predictors of persistence versus remittance. Likewise, the development of comorbid disorders cannot be foreseen early on, hampering preventive measures. These facts call for a lifespan perspective on ADHD from childhood to old age. In this selective review, we summarise current knowledge of the long-term course of ADHD, with an emphasis on clinical symptom and cognitive trajectories, treatment effects over the lifespan, and the development of comorbidities. Also, we summarise current knowledge and important unresolved issues on biological factors underlying different ADHD trajectories. We conclude that a severe lack of knowledge on lifespan aspects in ADHD still exists for nearly every aspect reviewed. We encourage large-scale research efforts to overcome those knowledge gaps through appropriately granular longitudinal studies. (c) 2018 Radboud University Medical Center. Published by Elsevier B.V.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据